Editor’s voice: December 2013 and a look ahead to 2014
Rebecca Aris reviews her personal highlights from pharmaphorum’s content this past month and shares what’s to come in 2014, including a look at who will be joining pharmaphorum’s editorial team in January.
Do extroverts or introverts make the best leaders, questioned Rob Dickerson of Menarini, in his article published this month? The article received praise through forum comments on the article itself, in addition to discussion comments in our LinkedIn group and was one of my personal highlights this month. In addition to challenging the false beliefs surrounding introverts and their leadership qualities, Rob highlights how ‘extremes at both ends of the spectrum of introversion and extroversion do not make successful leaders’, offering us real food for thought.
“Do extroverts or introverts make the best leaders, questioned Rob Dickerson of Menarini, in his article published this month…”
Prof. Meir Perez Pugatch looked at the case of Teva in Israel in the article ‘When national champions fall – The case of Teva requires us to revise our thinking about national champions and national interests‘. Whilst exploring Teva’s previous success in Israel, Prof. Pugatch highlights recent challenges faced by the company and how ‘the example of Teva and Israel provides lessons that go far beyond Israel’s borders.’
In the latest article by Eli Lilly and Company, Bill Reid explored one of the biggest threats to adequate health care across the globe – counterfeit drugs, in his article, Countering counterfeit drugs. Bill wrote of recent progress that could help to limit the volume of counterfeits being accessed by patients and also of Lilly’s commitment to tackling this global challenge.
Daniel Ghinn’s list of his top-ten favourite pharma social media ‘firsts’ of the 2013 was one of our most read pieces this month. Daniel listed social meida efforts such as Janssen’s Tumblr initiative to engage people living with HIV, GSK’s facebook page, which actively engages 90,000 followers, and the loss of $160m by Chinese pharmaceutical company Renhe Pharma following a social media crisis. Daniel’s ‘Pharma gets social’ series exploring the social media activities of pharma companies will continue into 2014 as one of our most popular series.
Other popular thought leadership articles published this month include:-
- A look at how the affordable care act will affect your recruiting by Robyn Melhuish
- An insight into how personalized medicine can attack the #1 killer in the US by Tom Callis
- An introduction to the new NHS in England by Independent health economist, Leela Barham
- A look at what’s new on the online HCP resource, Univadis, by Shona Davies
“In the latest article by Eli Lilly and Company, Bill Reid explored one of the biggest threats to adequate health care across the globe – counterfeit drugs…”
What’s to come in the year ahead?
Those among you with sharp eyes may have noted at the bottom of our Christmas Eve article ‘What will Santa bring pharma this year?‘ that Jacky Law will be joining pharmaphorum in January as Managing Editor of premium media. We look forward to her starting with us in 2014, and I strongly encourage you to read her amusing festive piece if you haven’t already.
Also in January you can expect to find content on our themes of the month, ‘Health technology’ and ‘Central nervous system disorders’. Within these themes we have the following topics lined up, to name a few:-
- Strategic thinking for international markets with regard to eHealth
- Health Technology Trends in Latin America and Brazil
- The road ahead: where digital communications is leading the industry
- The issue of switching between branded and generic versions of epilepsy medications
- Nervous System (NS) Diseases: an ever-increasing cost for society
So look out for these interesting thought-leadership articles in January in addition to more content from our new Managing Editor of premium media.
Until next month, I do hope you continue to enjoy our content and please do enjoy a very Happy New Year!
About the author:
Rebecca Aris is Managing Editor of pharmaphorum, a very fast growing online thought leadership channel for pharma, representing an audience of senior pharma execs from all over the world.
Rebecca was the first full time employee to join pharmaphorum, starting in her current role in mid-2010, and is responsible for coordinating all editorial content on the site. Prior to working at pharmaphorum she was a medical writer at a healthcare PR agency. In addition, she spent three years working as a commissioning editor on three journal titles at a biomedical publishing company. Rebecca holds a BSc (Hons) in pharmaceutical science.
Closing thought: what would you like to see on pharmaphorum in 2014?